Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]

We had conducted phase 1/2 studies of cancer vaccination therapy using neo-tumor antigens in patients with refractory/persistent cervical cancer (CC) and ovarian cancer (OC) to assess the feasibility and efficacy. Enrollees must be refractory/persistent disease for usual treatments with Human Leukoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Satoshi, Kagabu, Masahiro, Shoji, Tadahiro, Nitta, Yukari, Sugiyama, Toru, Sato, Junya, Nakamura, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671072/
https://www.ncbi.nlm.nih.gov/pubmed/33235818
http://dx.doi.org/10.1080/2162402X.2020.1838189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671072/
https://www.ncbi.nlm.nih.gov/pubmed/33235818
http://dx.doi.org/10.1080/2162402X.2020.1838189

Ejemplares similares